|
|
|
| Characteristics of the first-visit cases of herpes zoster in Zhoushan City |
| LENG Xue1, FU Shuqin2, SHU Jiwei3, TAN Qilong3, LI Kefeng4
|
1. Zhoushan Hospital, Zhoushan, Zhejiang 316000, China;
2. Daishan County Hospital of Traditional Chinese Medicine, Daishan, Zhejiang 316200, China;
3. Daishan County Center for Disease Control and Prevention, Daishan, Zhejiang 316200, China;
4. Zhoushan Center for Disease Control and Prevention, Zhoushan, Zhejiang 316000, China |
|
|
|
|
Abstract Objective To analyze the characteristics of first-visit cases of herpes zoster in Zhoushan City, Zhejiang Province from 2021 to 2023, so as to provide the reference for improving herpes zoster prevention and control measures. Methods Data on the incidence and vaccination of first-visit herpes zoster cases at all levels of public medical institutions in Zhoushan City from 2021 to 2023 were collected through the Zhoushan Comprehensive Health Information Platform and Zhoushan Immunization Program Information Management System. The incidence and outpatient proportion were calculated. The population distribution, seasonal distribution, and clinical consultation status of first-visit herpes zoster cases were described. Results From 2021 to 2023, a total of 15 156 first-visit herpes zoster cases were reported in Zhoushan City, with an average annual incidence of 5.36‰. The incidences for each year were 5.78‰, 5.29‰ and 5.02‰, respectively, and the outpatient proportions were 0.15%, 0.14% and 0.11%, respectively, showed decreasing trends (both P<0.05). The number of doses of recombinant herpes zoster vaccine or live attenuated herpes zoster vaccine administered were 130, 312, and 633, respectively. The main consultation department was dermatology, with 11 004 cases (72.60%). The primary clinical diagnosis was visceral herpes zoster, with 5 901 cases (38.94%). A total of 1 936 cases (12.77%) had at least one underlying medical condition. The mean age of onset was (56.08±16.23) years, and the incidence showed an upward trend with increasing age (P<0.05). There were 7 386 male cases and 7 770 female cases, with a male-to-female ratio of 0.95∶1. The incidence among males aged ≥50 years was lower than that among females (6.53‰ vs. 8.69‰, P<0.05). The onset of the disease exhibited a significant seasonal pattern, with a peak period from June 21st to August 21st, covering 75% of the cases. Conclusions From 2021 to 2023, the incidence and outpatient proportion of herpes zoster in Zhoushan City decreased. Summer was the peak season for onset, and women and the elderly were the key populations. It is necessary to strengthen the collaborative diagnostic and treatment capabilities of key departments such as dermatology and enhance the enthusiasm for vaccination among key populations.
|
|
Received: 26 December 2024
Revised: 06 June 2025
Published: 23 July 2025
|
|
|
|
|
|
[1] 中国医师协会皮肤科医师分会带状疱疹专家共识工作组,国家皮肤与免疫疾病临床医学研究中心.中国带状疱疹诊疗专家共识(2022版)[J].中华皮肤科杂志,2022,55(12):1033-1040.
Consensus Workgroup on Herpes Zoster,China Dermatologist Association,National Clinical Research Center for Skin and Immune Diseases.Chinese consensus on the diagnosis and management of herpes zoster(2022)[J].Chin J Dermatol,2022,55(12):1033–1040.(in Chinese)
[2] PATIL A,GOLDUST M,WOLLINA U.Herpes zoster:a review of clinical manifestations and management[J/OL].Viruses,2022,14(2)[2025-06-06].https://doi.org/10.3390/v14020192.
[3] LI Y,AN Z J,YIN D P,et al.Disease burden due to herpes zoster among population aged ≥50 years old in China:a community based retrospective survey[J/OL].PLoS One,2016,11(4)[2025-06-06].https://doi.org/10.1371/journal.pone.0152660.
[4] 张娇,郭晓璟,李书明,等.北京市朝阳区≥50岁慢性病患者带状疱疹疫苗接种率和接种意愿[J].中国疫苗和免疫,2023,29(6):687-693.
ZHANG J,GUO X J,LI S M,et al.Herpes zoster vaccine coverage and willingness to receive the vaccine among ≥50-year-old patients with chronic diseases in Chaoyang district of Beijing[J].Chin J Vaccines Immunization,2023,29(6):687-693.(in Chinese)
[5] 王静,叶冬青.圆分布分析方法及实例应用[J].疾病控制杂志,2004,8(2):160-161.
WANG J,YE D Q.The circular distribution analysis and application[J].Chin J Dis Control Prev,2004,8(2):160-161.(in Chinese)
[6] 朱宗龙,杨俊英,许颖.2021年北京市昌平区带状疱疹首次就诊病例流行病学特征分析[J].疾病预防控制通报,2023,38(6):50-53.
ZHU Z L,YANG J Y,XU Y.Analysis of epidemiological characteristics of first visit patients with herpes zoster in Changping district of Beijing,2021[J].Bull Dis Control Prev Dec,2023,38(6):50-53.(in Chinese)
[7] 罗秀兰,郑永韬,倪梦姣,等.一起带状疱疹病例引起的医院水痘暴发疫情调查[J].预防医学,2025,37(5):490-493.
LUO X L,ZHENG Y T,NI M J,et al.Epidemiological investigation of a nosocomial varicella outbreak triggered by a herpes zoster case[J].China Prev Med J,2025,37(5):490-493.(in Chinese)
[8] 刘娜,栾琳,张钧,等.带状疱疹的临床和流行病学特征综述[J].中国疫苗和免疫,2023,29(1):102-112.
LIU N,LUAN L,ZHANG J,et al.Clinical and epidemiological characteristics of herpes zoster:a literature review[J].Chin J Vaccines Immunization,2023,29(1):102-112.(in Chinese)
[9] 王敏,高静,冯玫.常见慢性病与带状疱疹相关性的研究进展[J].中华全科医师杂志,2024,23(4):419-424.
WANG M,GAO J,FENG M.Research progress on association between chronic diseases and herpes zoster[J].Chin J Gen Pract,2024,23(4):419-424.(in Chinese)
[10] GROSS G E,EISERT L,DOERR H W,et al.S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia[J].J Dtsch Dermatol Ges,2020,18(1):55-78.
[11] MUÑOZ-QUILES C,LÓPEZ-LACORT M,AMPUDIA-BLASCO F J,et al.Risk and impact of herpes zoster on patients with diabetes:a population-based study,2009-2014[J].Hum Vaccin Immunother,2017,13(11):2606-2611.
[12] KAWAI K,YAWN B P.Risk factors for herpes zoster:a systematic review and meta-analysis[J].Mayo Clin Proc,2017,92(12):1806-1821.
[13] KAWAI K,VOPHAM T,DRUCKER A,et al.Ultraviolet ra-diation exposure and the risk of herpes zoster in three pro-spective cohort studies[J].Mayo Clin Proc,2020,95(2):283-292. |
|
|
|
